Companies
Health Care
383 companies, ranked by market cap.
| Company | Sector | Market cap β | Price | Day | Revenue | Growth | Op. margin | P/E |
|---|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals, Inc.RYTM | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $190M | 45.8% | β101.2% | β |
| Mirum Pharmaceuticals, Inc.MIRM | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $521M | 54.7% | β4.2% | β |
| Ptc Therapeutics, Inc.PTCT | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $1.7B | 114.5% | 50.1% | β |
| Travere Therapeutics, Inc.TVTX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $491M | 110.5% | β12.8% | β |
| Tango Therapeutics, Inc.TNGX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $62.4M | 48.3% | β178.4% | β |
| Dianthus Therapeutics, Inc. /DE/DNTH | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $2.0M | β67.3% | β8,739.3% | β |
| Arcutis Biotherapeutics, Inc.ARQT | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $376M | 91.3% | β3.3% | β |
| AbCellera Biologics Inc.ABCL | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $75.1M | 160.6% | β289.0% | β |
| Amylyx Pharmaceuticals, Inc.AMLX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β100.0% | β | β |
| Organon & Co.OGN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $6.2B | β2.9% | β | β |
| Xenon Pharmaceuticals Inc.XENE | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $7.5M | β | β4,974.3% | β |
| Liquidia CorpLQDA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $158M | 1,031.2% | β32.5% | β |
| IDEAYA Biosciences, Inc.IDYA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $219M | 3,024.4% | β72.8% | β |
| Viking Therapeutics, Inc.VKTX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β | β | β |
| Nurix Therapeutics, Inc.NRIX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $84.0M | 54.0% | β340.2% | β |
| Maravai Lifesciences Holdings, Inc.MRVI | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $186M | β28.3% | β115.9% | β |
| Zai Lab LtdZLAB | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $460M | 15.3% | β49.9% | β |
| Viridian Therapeutics, Inc.\DEVRDN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $70.8M | 23,359.9% | β512.9% | β |
| NewAmsterdam Pharma Co N.V.NAMS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $22.5M | β50.6% | β1,002.9% | β |
| Arcus Biosciences, Inc.RCUS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $247M | β4.3% | β156.3% | β |
| Supernus Pharmaceuticals, Inc.SUPN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $719M | 8.6% | β8.7% | β |
| Precigen, Inc.PGEN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $9.7M | 146.7% | β1,141.1% | β |
| Prestige Consumer Healthcare Inc.PBH | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $1.1B | β4.3% | 28.4% | β |
| Aurinia Pharmaceuticals Inc.AUPH | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $283M | 20.4% | 37.1% | β |
| Agios Pharmaceuticals, Inc.AGIO | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $54.0M | 48.0% | β873.9% | β |
| PERRIGO Co plcPRGO | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $4.3B | β2.8% | β26.4% | β |
| Immunome Inc.IMNM | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $6.9M | β23.2% | β3,228.8% | β |
| Zymeworks Inc.ZYME | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $106M | 38.9% | β87.3% | β |
| Xeris Biopharma Holdings, Inc.XERS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $292M | 43.7% | 8.5% | β |
| Sarepta Therapeutics, Inc.SRPT | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $2.2B | 15.6% | β31.8% | β |
| Septerna, Inc.SEPN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $46.0M | 4,174.5% | β148.6% | β |
| Zenas BioPharma, Inc.ZBIO | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $10.0M | 100.0% | β3,830.6% | β |
| Xencor IncXNCR | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $126M | 13.7% | β141.4% | β |
| Palvella Therapeutics, Inc.PVLA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $2.6M | 303.4% | β1,490.4% | β |
| Schrodinger, Inc.SDGR | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $256M | 23.3% | β65.2% | β |
| UroGen Pharma Ltd.URGN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $110M | 21.4% | β113.7% | β |
| Nuvation Bio Inc.NUVB | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $62.9M | 699.0% | β338.7% | β |
| Stoke Therapeutics, Inc.STOK | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $184M | 404.5% | β11.2% | β |
| Phibro Animal Health CorpPAHC | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $1.5B | 17.1% | 12.8% | β |
| Ultragenyx Pharmaceutical Inc.RARE | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $673M | 20.2% | β79.5% | β |
| uniQure N.V.QURE | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $16.1M | β40.6% | β1,151.4% | β |
| Pacira BioSciences, Inc.PCRX | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $726M | 3.6% | 2.6% | β |
| Korsana Biosciences, Inc.KRSA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $2.1M | 3.7% | β239.8% | β |
| Anaptysbio, IncANAB | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $235M | 157.0% | 96.7% | β |
| Eton Pharmaceuticals, Inc.ETON | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $80.0M | 104.9% | β1.1% | β |
| Ocular Therapeutix, IncOCUL | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $52.0M | β18.5% | β519.8% | β |
| Damora Therapeutics, Inc.DMRA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $1.2M | 38.3% | β18,069.6% | β |
| Nektar TherapeuticsNKTR | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $55.2M | β43.9% | β253.7% | β |
| Silence Therapeutics plcSLN | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.6M | β98.7% | β16,292.8% | β |
| Opko Health, Inc.OPK | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $607M | β14.9% | β19.3% | β |